Abbvie Overview
Abbvie Target Price
Analysts' 12-month price predictions for ABBV.
Share Price
$185.58
Average Target Price
$217.50
17.2% upside
17.2% upside2 analysts in the last 4 months
High: $220 | Low: $215
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-03 | Raymond JamesGary Nachman | $220 | 18.5% upside |  |
| 2025-02-03 | BMO CapitalEvan Seigerman | $215 | 15.9% upside | |
| 2024-11-12 | BMO CapitalEvan David Seigerman | $208 | 12.1% upside | |
| 2024-10-31 | CitigroupGeoff Meacham | $226 | 21.8% upside | |
| 2024-10-31 | Bank of America SecuritiesCharlie Yang | $210 | 13.2% upside | |
| 2024-10-31 | BMO CapitalEvan David Seigerman | $228 | 22.9% upside | |
| 2024-10-18 | Bank of America SecuritiesGeoff Meacham | $195 | 5.1% upside | |
| 2024-10-17 | BernsteinCourtney Breen | $203 | 9.4% upside | |
| 2024-08-23 | Raymond JamesChristopher Raymond | $209 | 12.6% upside | |
| 2024-07-19 | BMO CapitalEvan Seigerman | $214 | 15.3% upside | |
| 2024-06-18 | Raymond JamesChristopher Raymond | $190 | 2.4% upside | |
| 2024-06-05 | HSBCRajesh Kumar | $185 |  0.3% downside | |
| 2024-05-24 | Deutsche BankJames Shin | $175 | 5.7% downside | |
| 2024-05-17 | Cantor FitzgeraldLouise Chen | $200 | 7.8% upside | |
| 2024-04-29 | BMO CapitalEvan Seigerman | $180 | 3% downside | |
| 2024-03-27 | BarclaysCarter Gould | $195 | 5.1% upside | |
| 2024-01-29 | William BlairTim Lugo | $190 | 2.4% upside | |
| 2023-11-09 | Raymond JamesChristopher Raymond | $170 | 8.4% downside | |
| 2023-09-29 | Raymond JamesGary Nachman | $177 | 4.6% downside | |
| 2023-05-09 | GuggenheimVamil Divan | $171 | 7.9% downside | |
| 2023-02-06 | BMO Capital | $167 | 10% downside | |
| 2022-12-06 | Morgan Stanley | $182 | 1.9% downside | |
| 2022-11-18 | Credit Suisse | $170 | 8.4% downside | |
| 2022-09-30 | Leerink Partners | $135 | 27.3% downside | |
| 2022-08-24 | Argus Research | $155 | 16.5% downside | |
| 2022-08-01 | Barclays | $160 | 13.8% downside | |
| 2022-07-14 | Morgan StanleyTerence Flynn | $191 | 2.9% upside | |
| 2022-05-24 | Leerink PartnersDavid Risinger | $140 | 24.6% downside | |
| 2022-05-22 | Berenberg BankLuisa Hector | $135 | 27.3% downside | |
| 2022-05-03 | Morgan StanleyTerence Flynn | $188 | 1.3% upside | |
| 2022-05-02 | Wells Fargo | $200 | 7.8% upside | |
| 2022-04-26 | BMO CapitalGary Nachman | $174 | 6.2% downside | |
| 2022-04-16 | BarclaysCarter Gould | $174 | 6.2% downside | |
| 2022-04-06 | Morgan StanleyTerence Flynn | $192 | 3.5% upside | |
| 2022-03-05 | UBSNavin Jacob | $147 | 20.8% downside | |
| 2022-02-21 | Truist FinancialRobyn Karnauskas | $160 | 13.8% downside | |
| 2022-02-06 | Mizuho SecuritiesVamil Divan | $166 | 10.6% downside | |
| 2022-02-03 | J.P. MorganChris Schott | $180 | 3% downside | |
| 2022-02-03 | BarclaysCarter Gould | $150 | 19.2% downside | |
| 2022-02-02 | Piper SandlerChristopher Raymond | $160 | 13.8% downside | |
| 2022-02-01 | Evercore ISIJoshua Schimmer | $133 | 28.3% downside | |
| 2022-01-29 | CitigroupAndrew Baum | $155 | 16.5% downside | |
| 2022-01-18 | Cowen & Co.Steve Scala | $150 | 19.2% downside | |
| 2022-01-18 | BMO CapitalGary Nachman | $153 | 17.6% downside | |
| 2022-01-03 | BernsteinAaron Gal | $155 | 16.5% downside | |
| 2021-12-08 | Wells FargoMohit Bansal | $165 | 11.1% downside | |
| 2021-11-23 | Societe GeneraleJustin Smith | $172 | 7.3% downside | |
| 2021-08-05 | Argus ResearchDavid Toung | $140 | 24.6% downside | |
| 2021-08-01 | RBC CapitalDaniel Busby | $135 | 27.3% downside | |
| 2021-05-03 | Wolfe ResearchTim Anderson | $127 | 31.6% downside | |